Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 28, 2020 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and…